Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity

Toxicology and Applied Pharmacology

Volumn 245, Issue 1, 2010, Pages 36-46

  Gardner, Carol R ^a   Gray, Joshua P ^b   Joseph, Laurie B ^a   Cervelli, Jessica ^a   Bremer, Nicole ^a   Kim, Yunjung ^a   Mishin, Vladimir ^a   Laskin, Jeffrey D ^c   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b U S COAST GUARD ACADEMY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Acetaminophen; Antioxidants; Caveolin 1; Cytokines; Liver; Proliferation

Indexed keywords

AMINOTRANSFERASE; ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; CAVEOLIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLINE; CYCLOOXYGENASE 2; CYTOKINE; GLUTATHIONE; HEME OXYGENASE 1; INTERLEUKIN 1BETA; LIPOCALIN; LIPOXIN; MESSENGER RNA; MITOGENIC AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; PARACETAMOL; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GENE DISRUPTION; GENE EXPRESSION; GENOTYPE; INFLAMMATION; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; TISSUE REPAIR; TRANSGENIC MOUSE; UPREGULATION;

ACETAMINOPHEN; ANIMALS; ANTIOXIDANTS; CAVEOLIN 1; CELL PROLIFERATION; CHEMOKINE CCL2; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; LIVER; MALE; MICE; MICE, KNOCKOUT;

MUS; MUS MUSCULUS;

EID: 77952541984     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.01.008     Document Type: Article

References (80)

1. Aleksunes L.M., Slitt A.L., Maher J.M., Augustine L.M., Goedken M.J., Chan J.Y., Cherrington N.J., Klaassen C.D., Manautou J.E. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol. Appl. Pharmacol. 2008, 226:74-83.
2. Altieri D.C. New wirings in the survivin networks. Oncogene 2008, 27:6276-6284.
3. Baba H.A., Wohlschlaeger J., Schmitz K.J., Nadalin S., Lang H., Benesch A., Gu Y., Biglarnia A.R., Sotiropoulos G.C., Takeda A., Takeda N., von Wnuck Lipinski K., Levkau B. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int. 2009, 29:585-592.
4. Bourdi M., Korrapati M.C., Chakraborty M., Yee S.B., Pohl L.R. Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochem. Biophys. Res. Commun. 2008, 374:6-10.
5. Bouwens L., Knook D.L., Wisse E. Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats. J. Leukoc. Biol. 1986, 39:687-697.
6. Bower W.A., Johns M., Margolis H.S., Williams I.T., Bell B.P. Population-based surveillance for acute liver failure. Am. J. Gastroenterol. 2007, 102:2459-2463.
7. Bruccoleri A., Gallucci R., Germolec D.R., Blackshear P., Simeonova P., Thurman R.G., Luster M.I. Induction of early-immediate genes by tumor necrosis factorα contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 1997, 25:133-141.
8. Brunner L.J., Bai S. Simple and rapid assay for acetaminophen and conjugated metabolites in low-volume serum samples. J. Chromatogr., B, Biomed. Sci. Appl. 1999, 732:323-329.
9. Calvo M., Tebar F., Lopez-Iglesias C., Enrich C. Morphologic and functional characterization of caveolae in rat liver hepatocytes. Hepatology 2001, 33:1259-1269.
10. Canbay A., Bechmann L., Gerken G. Lipid metabolism in the liver. Z. Gastroenterol. 2007, 45:35-41.
11. Chiu H., Gardner C.R., Dambach D.M., Brittingham J.A., Durham S.K., Laskin J.D., Laskin D.L. Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am. J. Physiol.: Gastrointest. Liver Physiol. 2003, 285:G959-G966.
12. Chiu H., Gardner C.R., Dambach D.M., Durham S.K., Brittingham J.A., Laskin J.D., Laskin D.L. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol. Appl. Pharmacol. 2003, 193:218-227.
13. Cooper K.O., Reik L.M., Jayyosi Z., Bandiera S., Kelley M., Ryan D.E., Daniel R., McCluskey S.A., Levin W., Thomas P.E. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 1993, 301:345-354.
14. Cozma L.G., Alexa I.D., Dobrescu G. Transcriptional and electron microscopic analysis of extracellular matrix proteoglycans in acute acetaminophen intoxication. Rev. Med. Chir. Soc. Med. Nat. Iasi 2004, 108:452-457.
15. Dambach D.M., Watson L.M., Gray K.R., Durham S.K., Laskin D.L. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002, 35:1093-1103.
16. Dambach D.M., Durham S.K., Laskin J.D., Laskin D.L. Distinct roles of NF-κB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol. Appl. Pharmacol. 2006, 211:157-165.
17. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
18. Fakhrzadeh L., Laskin J.D., Laskin D.L. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation. Toxicol. Appl. Pharmacol. 2008, 227:380-389.
19. Fausto N., Campbell J.S., Riehle K.J. Liver regeneration. Hepatology 2006, 43:S45-53.
20. Fernandez M.A., Albor C., Ingelmo-Torres M., Nixon S.J., Ferguson C., Kurzchalia T., Tebar F., Enrich C., Parton R.G., Pol A. Caveolin-1 is essential for liver regeneration. Science 2006, 313:1628-1632.
21. Ferret P.J., Hammoud R., Tulliez M., Tran A., Trebeden H., Jaffray P., Malassagne B., Calmus Y., Weill B., Batteux F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001, 33:1173-1180.
22. Fujimoto K., Kumagai K., Ito K., Arakawa S., Ando Y., Oda S., Yamoto T., Manabe S. Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol. Pathol. 2009, 37:193-200.
23. Gardner C.R., Laskin D.L. Sinusoidal cells in liver injury and repair. Hepatotoxicity: from Genomics to In Vitro and In Vivo Models 2007, 341-370. West Sussex, John Wiley & Sons. S. Sahu (Ed.).
24. Gardner C.R., Laskin J.D., Dambach D.M., Sacco M., Durham S.K., Bruno M.K., Cohen S.D., Gordon M.K., Gerecke D.R., Zhou P., Laskin D.L. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-α and interleukin-10. Toxicol. Appl. Pharmacol. 2002, 184:27-36.
25. Gardner C.R., Laskin J.D., Dambach D.M., Chiu H., Durham S.K., Zhou P., Bruno M., Gerecke D.R., Gordon M.K., Laskin D.L. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol. Appl. Pharmacol. 2003, 192:119-130.
26. Gassmann M.G., Werner S. Caveolin-1 and -2 expression is differentially regulated in cultured keratinocytes and within the regenerating epidermis of cutaneous wounds. Exp. Cell Res. 2000, 258:23-32.
27. Gharaee-Kermani M., Phan S.H. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr. Pharm. Des. 2001, 7:1083-1103.
28. Goetz J.G., Lajoie P., Wiseman S.M., Nabi I.R. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev. 2008, 27:715-735.
29. Han D., Ybanez M.D., Ahmadi S., Yeh K., Kaplowitz N. Redox regulation of tumor necrosis factor signaling. Antioxid. Redox Signal. 2009, 11:2245-2263.
30. Harizi H., Corcuff J.B., Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 2008, 14:461-469.
31. Haruyama T., Ajioka I., Akaike T., Watanabe Y. Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem. Biophys. Res. Commun. 2000, 272:681-686.
32. Hogaboam C.M., Bone-Larson C.L., Steinhauser M.L., Matsukawa A., Gosling J., Boring L., Charo I.F., Simpson K.J., Lukacs N.W., Kunkel S.L. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am. J. Pathol. 2000, 156:1245-1252.
33. Holt M.P., Cheng L., Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukoc. Biol. 2008, 84:1410-1421.
34. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J. Pharmacol. Exp. Ther. 1990, 255:935-941.
35. Koop D.R. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 1986, 29:399-404.
36. Koslowski R., Barth K., Augstein A., Tschernig T., Bargsten G., Aufderheide M., Kasper M. A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem. Cell Biol. 2004, 121:509-519.
37. Kronke G., Katzenbeisser J., Uderhardt S., Zaiss M.M., Scholtysek C., Schabbauer G., Zarbock A., Koenders M.I., Axmann R., Zwerina J., Baenckler H.W., van den Berg W., Voll R.E., Kuhn H., Joosten L.A., Schett G. 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 2009, 183:3383-3389.
38. Laskin D.L. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem. Res. Toxicol. 2009, 22:1376-1385.
39. Laskin D.L., Gardner C.R. Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. Drug-Induced Liver Disease 2007, 159-184. Informa Heatlthcare, New York. N. Kaplowitz, L.D. DeLeve (Eds.).
40. Le Lay S., Kurzchalia T.V. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim. Biophys. Acta 2005, 1746:322-333.
41. Ledda-Columbano G.M., Curto M., Piga R., Zedda A.I., Menegazzi M., Sartori C., Shinozuka H., Bluethmann H., Poli V., Ciliberto G., Columbano A. In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 1998, 17:1039-1044.
42. Lee S.S., Buters J.T., Pineau T., Fernandez-Salguero P., Gonzalez F.J. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 1996, 271:12063-12067.
43. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584.
44. Liu Z.X., Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2006, 2:493-503.
45. Lopez-Rivera E., Lizarbe T.R., Martinez-Moreno M., Lopez-Novoa J.M., Rodriguez-Barbero A., Rodrigo J., Fernandez A.P., Alvarez-Barrientos A., Lamas S., Zaragoza C. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration. Proc. Natl. Acad. Sci. USA 2005, 102:3685-3690.
46. Malerod L., Juvet K., Gjoen T., Berg T. The expression of scavenger receptor class B, type I (SR-BI) and caveolin-1 in parenchymal and nonparenchymal liver cells. Cell Tissue Res. 2002, 307:173-180.
47. Mayoral R., Fernandez-Martinez A., Roy R., Bosca L., Martin-Sanz P. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Hepatology 2007, 46:813-822.
48. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 2005, 33:41-51.
49. Mendieta-Condado E., Pichardo-Olvera M., Sanchez-Sevilla L., Chagoya de Sanchez V., Hernandez-Munoz R. Adenosine administration accelerates progression of the cell cycle during rat liver regeneration induced by one-third hepatectomy. J. Pharmacol. Exp. Ther. 2009, 331:122-132.
50. Mita A.C., Mita M.M., Nawrocki S.T., Giles F.J. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin. Cancer Res. 2008, 14:5000-5005.
51. Mladenovic D., Radosavljevic T., Ninkovic M., Vucevic D., Jesic-Vukicevic R., Todorovic V. Liver antioxidant capacity in the early phase of acute paracetamol-induced liver injury in mice. Food Chem. Toxicol. 2009, 47:866-870.
52. Nakae D., Yamamoto K., Yoshiji H., Kinugasa T., Maruyama H., Farber J.L., Konishi Y. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am. J. Pathol. 1990, 136:787-795.
53. Odajima N., Betsuyaku T., Nasuhara Y., Nishimura M. Loss of caveolin-1 in bronchiolization in lung fibrosis. J. Histochem. Cytochem. 2007, 55:899-909.
54. Ogi M., Yokomori H., Oda M., Yoshimura K., Nomura M., Ohshima S., Akita M., Toda K., Ishii H. Distribution and localization of caveolin-1 in sinusoidal cells in rat liver. Med. Electron Microsc. 2003, 36:33-40.
55. Okamoto H., Kimura M., Watanabe N., Ogihara M. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of endogenous transforming growth factor-α Eur. J. Pharmacol. 2009, 604:12-19.
56. Orfila C., Lepert J.C., Alric L., Carrera G., Beraud M., Vinel J.P., Pipy B. Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem. J. 1999, 31:677-685.
57. Parat M.O. The biology of caveolae: achievements and perspectives. Int. Rev. Cell Mol. Biol. 2009, 273:117-162.
58. Pol A., Martin S., Fernandez M.A., Ferguson C., Carozzi A., Luetterforst R., Enrich C., Parton R.G. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 2004, 15:99-110.
59. Quest A.F., Leyton L., Parraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol. 2004, 82:129-144.
60. Quest A.F., Gutierrez-Pajares J.L., Torres V.A. Caveolin-1: an ambiguous partner in cell signalling and cancer. J. Cell Mol. Med. 2008, 12:1130-1150.
61. Ramachandran R., Kakar S. Histological patterns in drug-induced liver disease. J. Clin. Pathol. 2009, 62:481-492.
62. Reed J.C. The survivin saga goes in vivo. J. Clin. Invest. 2001, 108:965-969.
63. Reilly T.P., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., Pise-Masison C.A., Pohl L.R. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 2001, 14:1620-1628.
64. Roderfeld M., Geier A., Dietrich C.G., Siewert E., Jansen B., Gartung C., Roeb E. Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury. Liver Int. 2006, 26:579-586.
65. Romano M. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. Inflamm. Allergy Drug Targets 2006, 5:81-90.
66. Roudkenar M.H., Kuwahara Y., Baba T., Roushandeh A.M., Ebishima S., Abe S., Ohkubo Y., Fukumoto M. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. J. Radiat. Res. (Tokyo) 2007, 48:39-44.
67. 2 toxicity. Arch. Med. Res. 2008, 39:560-566.
68. Rutherford A., Chung R.T. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin. Liver Dis. 2008, 28:167-174.
69. Serhan C.N. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. J. Periodontol. 2008, 79:1520-1526.
70. Shah V., Cao S., Hendrickson H., Yao J., Katusic Z.S. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am. J. Physiol.: Gastrointest. Liver Physiol. 2001, 280:G1209-G1216.
71. Shatz M., Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. Int. J. Radiat. Biol. 2008, 84:177-189.
72. Shimizu T., Togo S., Kumamoto T., Makino H., Morita T., Tanaka K., Kubota T., Ichikawa Y., Nagasima Y., Okazaki Y., Hayashizaki Y., Shimada H. Gene expression during liver regeneration after partial hepatectomy in mice lacking type 1 tumor necrosis factor receptor. J. Surg. Res. 2009, 152:178-188.
73. Torres V.A., Tapia J.C., Rodriguez D.A., Parraga M., Lisboa P., Montoya M., Leyton L., Quest A.F. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J. Cell Sci. 2006, 119:1812-1823.
74. Vasiliou V., Ross D., Nebert D.W. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum. Genomics 2006, 2:329-335.
75. Williams T.M., Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann. Med. 2004, 36:584-595.
76. Wullaert A., van Loo G., Heyninck K., Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond. Endocr. Rev. 2007, 28:365-386.
77. Yamada Y., Kirillova I., Peschon J.J., Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 1997, 94:1441-1446.
78. Yamamoto T., Naito M., Moriyama H., Umezu H., Matsuo H., Kiwada H., Arakawa M. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. Am. J. Pathol. 1996, 149:1271-1286.
79. Yoshikawa Y., Morita M., Hosomi H., Tsuneyama K., Fukami T., Nakajima M., Yokoi T. Knockdown of superoxide dismutase 2 enhances acetaminophen-induced hepatotoxicity in rat. Toxicology 2009, 264:89-95.
80. Yuan L., Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol. Aspects Med. 2009, 30:29-41.